ABCC3 and breast carcinoma: Our data further revealed a novel observation that identifies the knockdown of ABCC3, but not ABCC1, sensitizes breast cancer cells to methotrexate, a routinely used drug to treat breast cancers, together highlighting an important role for ABCC3 in breast cancer drug resistance.